Trading Secrets: An Unwise Move In The Electronic Age

Law360, New York (April 12, 2012, 2:26 PM EDT) -- In the ongoing battle between competitors in the aesthetics field, the court in Allergan Inc. v. Merz Pharmaceuticals LLC, et al. recently completed a nine-day bench trial resulting in an injunction against the defendants to prevent the actual or threatened misappropriation of plaintiff Allergan Inc.’s trade secrets.

Allergan produces several different prescription medicines, including Botox Cosmetics and Juvederm, which are injectable treatments used to correct facial wrinkles and folds. Merz Aesthetics Inc. also had for years been in the facial aesthetics market, and had a product...
To view the full article, register now.